Traust Structured names M&A director to lead aerospace and defence push
Traust Structured, a Puerto Rico-based investment and operating platform, has appointed Erin Rooney as Managing Director for Strategic Growth and M&A, also granting her a shareholder stake in the business. The hire signals an acceleration of Traust's consolidation play across two sectors that rarely sit under the same holding company: time-critical medical aviation and US domestic defence drone manufacturing.
Rooney brings a background in advising business owners and investors through complex transactions in fragmented industries, where, the company says, strategic roll-up and access to capital can materially shift enterprise value. Her appointment as a shareholder, rather than a salaried executive alone, is a deliberate structural choice designed to tighten incentive alignment as Traust pursues further acquisitions.
Two platforms, one growth thesis
Her initial mandate covers Traust's two flagship initiatives. Traust Aviation is being built around the acquisition of an existing Part 135 operator with close to 50 years of operating history specialising in organ transportation, a highly regulated and time-sensitive niche. Traust's stated plan is to expand that operator nationally, adding hub infrastructure across the United States. Drone Campus, meanwhile, is a Kerrville, Texas-based initiative to aggregate domestic manufacturing capability for defence drone prime contractors, positioning itself as a supply-chain consolidator rather than a drone designer or end-user.
"I have spent my career looking for opportunities where exceptional people, strong underlying businesses and the right capital can create something significantly larger," Rooney said. "From strengthening domestic aerospace and defense manufacturing capabilities to expanding aviation infrastructure supporting time-critical medical transportation, these are businesses where execution matters."
The pairing of those two platforms is not accidental. Both sit in sectors where fragmentation is structural, regulatory barriers are high, and domestic production capacity has become a political priority. In organ transport aviation, the US market is served largely by small regional operators, many operating ageing fleets under Part 135 certificates, a certification class that permits on-demand commercial air operations. In defence drone manufacturing, the Pentagon and allied procurement agencies have repeatedly flagged dependence on foreign-made components, particularly from Chinese suppliers, as a strategic vulnerability.
Convergence of capital and capability
The broader investment landscape around both platforms is shifting in ways that make Traust's timing noteworthy. Defence-drone manufacturing has attracted a wave of capital since Russia's 2022 invasion of Ukraine demonstrated the asymmetric battlefield value of uncrewed systems, prompting NATO members to seek domestically sourced supply chains at scale. Meanwhile, the US medical logistics sector, largely invisible to institutional investors, has begun attracting private equity attention precisely because of its fragmentation and the regulatory moat that Part 135 certification creates.
Traust's model, combining structured capital with operational development rather than pure financial engineering, sits closer to industrial holding-company logic than to traditional defence-tech venture investment. That positioning may prove attractive to mid-market family offices and private credit providers looking for exposure to defence-adjacent infrastructure without the risk profile of early-stage hardware startups.
What remains thin in the public record is the scale of capital Traust has deployed or raised across these platforms, the timeline for national hub expansion in the aviation business, and the specific prime-contractor relationships underpinning the Drone Campus. Rooney's appointment suggests the company is preparing for a more active deal pipeline, but investors and partners evaluating Traust will want to see those specifics before the growth thesis can be fully tested.